STOPAIN CLINICAL Migraine and Headache

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
STOPAIN CLINICAL Migraine and Headache
Generic name
MENTHOL, UNSPECIFIED FORM, ATROPA BELLADONNA, IRIS VERSICOLOR ROOT, SANGUINARIA CANADENSIS ROOT
Manufacturer
Troy Manufacturing, Inc.
Product type
HUMAN OTC DRUG
SPL set ID
c5b690ce-7bb6-4840-b00b-205cd5bc6be6
SPL ID
f318667c-c615-79fc-e053-2995a90ae7cb
Version
3
Effective date
2023-01-25
Source export date
2026-09-28
Source partition
4
Source file
https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/c7ca0b7091cdaeab3f27713a6eef00adcf8fe722383633ddce61531b4c840544/drug-label-0004-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:26:30
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. This product should not be used topically on children younger than 2 years of age nor should it be applied on any mucus membranes of any age child or adult. Seek the advice of your healthcare professional before using this product topically on children 2-12 years of age. Avoid contact with eyes. If gel gets in eyes or on muscus membranes flush with cool water for 1-2 minutes Ask a doctor before use if you have never had migraines diagnosed by a health professional • Do not apply to broken or irritated skin • Do not apply to forehead or temples Keep out of reach of children. If swallowed, get medicial help or contact a Poison Control Center. Stop use and consult a doctor if • condition worsens or symptoms persist for more than 7 days or clear up and occur again within a few days • redness is present • excessive irritation of the skin occurs If pregnant or breast feeding ask a health professional before use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.